-
公开(公告)号:US5510501A
公开(公告)日:1996-04-23
申请号:US256711
申请日:1994-07-21
申请人: Hirofumi Nakano , Noboru Fujii , Yoshinori Yamashita , Yutaka Saitoh , Tsutomu Agatsuma , Katsuhiko Ando , Yasushi Nishiie , Katsunori Kita , Naoki Morishima , Katsushige Gomi
发明人: Hirofumi Nakano , Noboru Fujii , Yoshinori Yamashita , Yutaka Saitoh , Tsutomu Agatsuma , Katsuhiko Ando , Yasushi Nishiie , Katsunori Kita , Naoki Morishima , Katsushige Gomi
IPC分类号: C07C50/38 , C07C305/22 , C07C305/26 , C12P29/00 , C07C49/423
CPC分类号: C07C305/26 , C07C305/22 , C07C50/38 , C12P29/00
摘要: The present invention relates to Saintopin derivatives represented by the following formula (I): ##STR1## wherein R.sup.1 is hydrogen and R.sup.2 is SO.sub.2 OH (UCE 1022), or R.sup.1 is acetyl and R.sup.2 is H (Saintopin E), which are useful as antibacterial and anti-tumor agents.
摘要翻译: PCT No.PCT / JP93 / 01680 Sec。 371日期:1994年7月21日 102(e)日期1994年7月21日PCT 1993年11月17日PCT公布。 公开号WO94 / 12458 日本6月9日,1994年。本发明涉及由下式(I)表示的Saintopin衍生物:其中R1是氢,R2是SO2OH(UCE1022),或R1是乙酰基,R2是H (Saintopin E),其可用作抗细菌剂和抗肿瘤剂。
-
公开(公告)号:US5977165A
公开(公告)日:1999-11-02
申请号:US958285
申请日:1997-10-27
申请人: Tsutomu Agatsuma , Yutaka Saitoh , Yoshinori Yamashita , Tamio Mizukami , Shiro Akinaga , Katsushige Gomi , Kazuhito Akasaka , Isami Takahashi
发明人: Tsutomu Agatsuma , Yutaka Saitoh , Yoshinori Yamashita , Tamio Mizukami , Shiro Akinaga , Katsushige Gomi , Kazuhito Akasaka , Isami Takahashi
IPC分类号: C07D313/00 , A61K31/335
CPC分类号: C07D313/00
摘要: The present invention relates to radicicol derivatives represented by the following formula (I) or pharmacologically acceptable salts thereof: ##STR1## wherein R.sup.1 and R.sup.2 are the same or different and each represents hydrogen, alkanoyl, alkenoyl or tert-butyldimethylsilyl; (1) when X represents halogen, Y represents an oxygen atom or R.sup.4 --O--N (wherein R.sup.4 represents hydrogen or substituted or unsubstituted lower alkyl); and R.sup.3 represents hydrogen, alkanoyl, alkenoyl or the like; and (2) when X and R.sup.3 are combined with each other to represent a single bond; Y represents R.sup.4B --O--N (wherein R.sup.4B has the same meaning as R.sup.4). The radicicol derivatives of the present invention demonstrate tyrosine kinase inhibition activity and pharmacological activities such as antitumor, antimicrobial or immunosuppression effects.
摘要翻译: 本发明涉及由下式(I)表示的根赤壳菌素衍生物或其药理学上可接受的盐:其中R1和R2相同或不同,各自代表氢,烷酰基,烯酰基或叔丁基二甲基甲硅烷基; (1)当X表示卤素时,Y表示氧原子或R4-O-N(其中R4表示氢或取代或未取代的低级烷基); 和R3表示氢,烷酰基,烯酰基等; 和(2)当X和R 3相互结合以表示单键时; Y表示R4B-O-N(其中R4B与R4相同)。 本发明的根皮霉素衍生物显示出酪氨酸激酶抑制活性和药理活性,如抗肿瘤,抗微生物或免疫抑制作用。
-
公开(公告)号:US06869971B1
公开(公告)日:2005-03-22
申请号:US10110964
申请日:2000-10-19
申请人: Tsutomu Akama , Akira Asai , Tsutomu Agatsuma , Shinji Nara , Yoshinori Yamashita , Tamio Mizukami , Shun-ichi Ikeda , Yutaka Saitoh , Yutaka Kanda
发明人: Tsutomu Akama , Akira Asai , Tsutomu Agatsuma , Shinji Nara , Yoshinori Yamashita , Tamio Mizukami , Shun-ichi Ikeda , Yutaka Saitoh , Yutaka Kanda
IPC分类号: A61P31/04 , A61P35/00 , C07D487/04 , C07D487/14 , C07D487/16 , C07D491/14 , C07D491/147 , C07D491/16 , C07D498/08 , A61K31/403 , A61K31/4453 , C07D209/52 , C07D401/06
CPC分类号: C07D487/04 , C07D487/14 , C07D491/14
摘要: UCS 1025 derivatives having antitumor activity or antibacterial activity which are represented by formula (I): wherein R1 represents hydrogen, lower alkyl, etc.; R2 represents hydrogen, or is combined with R3 to represent a bond, etc., or is combined with R4 to represent —O(C═O)—, etc.; R3 represents hydrogen, etc., or is combined with R2 to represent a bond, etc.; R4 represents hydrogen, etc., or is combined with R2 to represent —(C═O)O—, etc.; R5 represents hydrogen or is combined with R6 to represent a bond; R6 represents hydrogen, etc., or is combined with R5 to represent a bond; R7 represents hydrogen or is combined with R8 to represent ═O; R8 represents hydroxy or is combined with R7 to represent ═O; ---- represents a single bond or a double bond, and a represents a single bond (two carbon atoms to which a is bound are combined to form a single bond) or an oxygen atom, or pharmaceutically acceptable salts thereof.
摘要翻译: 由式(I)表示的具有抗肿瘤活性或抗菌活性的UCS 1025衍生物:其中R 1表示氢,低级烷基等; R 2表示氢,或与R 3结合以表示键等,或与R 4结合以表示-O(C = O) - 等; R 3表示氢等,或与R 2结合以表示键等; R 4表示氢等,或与R 2结合代表 - (C = O)O-等; R 5表示氢或与R 6结合以表示键; R 6表示氢等,或与R 5结合以表示键; R 7表示氢或与R 8结合以代表= O; R 8表示羟基或与R 7结合代表= O; ----表示单键或双键,a表示单键(被结合形成单键的两个碳原子)或氧原子,或其药学上可接受的盐。
-
公开(公告)号:US5798379A
公开(公告)日:1998-08-25
申请号:US994029
申请日:1997-12-18
申请人: Tamio Mizukami , Harumi Ogawa , Ryuichiro Nakai , Akira Asai , Yoshinori Yamashita , Katsuhiko Ando , Tsutomu Agatsuma , Shiro Akinaga , Kozo Ouchi , Hideki Kawasaki
发明人: Tamio Mizukami , Harumi Ogawa , Ryuichiro Nakai , Akira Asai , Yoshinori Yamashita , Katsuhiko Ando , Tsutomu Agatsuma , Shiro Akinaga , Kozo Ouchi , Hideki Kawasaki
IPC分类号: C07D487/04 , C07D491/16 , C12P17/14 , A61K31/40 , C07D487/02
CPC分类号: C07D487/04 , C12P17/14
摘要: UCS1025 compounds represented by the following formula (I): ##STR1## wherein R represents hydrogen or hydroxyl group, or tautomers or pharmacologically acceptable salts thereof.
摘要翻译: 由下式(I)表示的UCS1025化合物:其中R表示氢或羟基,或互变异构体或其药理学上可接受的盐。
-
公开(公告)号:US5079376A
公开(公告)日:1992-01-07
申请号:US468915
申请日:1990-01-23
申请人: Hirofumi Nakano , Yoshinori Yamashita , Katsuhiko Ando , Yutaka Saito , Keiichi Takahashi , Hiroe Ohno
发明人: Hirofumi Nakano , Yoshinori Yamashita , Katsuhiko Ando , Yutaka Saito , Keiichi Takahashi , Hiroe Ohno
CPC分类号: C12R1/645 , C07C50/36 , C12P29/00 , C07C2103/44
摘要: Disclosed is novel compound UCT-1003 represented by the following formula: ##STR1## and having anti-tumor activity. UCT-1003 is produced by culturing a microorganism belonging to the genus Paecilomyces.
-
公开(公告)号:US4914198A
公开(公告)日:1990-04-03
申请号:US946842
申请日:1986-12-29
申请人: Hirofumi Nakano , Mitsunobu Hara , Yoshinori Yamashita , Isao Kawamoto , Katsuhiko Ando , Hiroshi Sano , Toru Yasuzawa , Katsuichi Shuto
发明人: Hirofumi Nakano , Mitsunobu Hara , Yoshinori Yamashita , Isao Kawamoto , Katsuhiko Ando , Hiroshi Sano , Toru Yasuzawa , Katsuichi Shuto
CPC分类号: C12P33/00 , C07J71/001
摘要: Novel substance UCY1003 produced by culturing of a microorganism has the following chemical structure and analgesic, hypotensive and antifungal activities: ##STR1##
摘要翻译: 通过培养微生物产生的新物质UCY1003具有以下化学结构和镇痛,降血压和抗真菌活性:
-
公开(公告)号:US5366966A
公开(公告)日:1994-11-22
申请号:US070962
申请日:1993-06-04
申请人: Hirofumi Nakano , Noboru Fujii , Yoshinori Yamashita , Youichi Uosaki , Shigeru Chiba , Shigeo Katsumata , Yukari Tsuji
发明人: Hirofumi Nakano , Noboru Fujii , Yoshinori Yamashita , Youichi Uosaki , Shigeru Chiba , Shigeo Katsumata , Yukari Tsuji
摘要: A compound represented by formula (I): ##STR1## or a pharmaceutically acceptable salt thereof is provided, which has an excellent antitumor activity.
摘要翻译: 提供由式(I)表示的化合物:其具有优异的抗肿瘤活性。
-
公开(公告)号:US5717110A
公开(公告)日:1998-02-10
申请号:US836314
申请日:1997-05-12
申请人: Tamio Mizukami , Akira Asai , Yoshinori Yamashita , Hirofumi Nakano , Shingo Kakita , Youichi Uosaki , Keiko Ochiai , Tadashi Ashizawa , Akira Mihara
发明人: Tamio Mizukami , Akira Asai , Yoshinori Yamashita , Hirofumi Nakano , Shingo Kakita , Youichi Uosaki , Keiko Ochiai , Tadashi Ashizawa , Akira Mihara
IPC分类号: C07D207/34 , C07D207/00
CPC分类号: C07D207/34
摘要: This invention relates to UCH15 compounds of the formula (I): ##STR1## wherein R.sup.1 represents a hydrogen atom or a hydroxyl group.
摘要翻译: PCT No.PCT / JP96 / 02587第 371日期:1997年5月12日 102(e)日期1997年5月12日PCT提交1996年9月11日PCT公布。 公开号WO97 / 10208 PCT 日本公开号为1997年3月20日本发明涉及式(I)的UCH15化合物:其中R 1表示氢原子或羟基。
-
公开(公告)号:US5656736A
公开(公告)日:1997-08-12
申请号:US424281
申请日:1995-04-21
申请人: Hirofumi Nakano , Harumi Ogawa , Yoshinori Yamashita , Ritsuko Katahira , Shigeru Chiba , Toshiaki Iwasaki , Tadashi Ashizawa
发明人: Hirofumi Nakano , Harumi Ogawa , Yoshinori Yamashita , Ritsuko Katahira , Shigeru Chiba , Toshiaki Iwasaki , Tadashi Ashizawa
IPC分类号: C07H15/24 , A61K31/70 , A61K31/7028 , A61K31/7034 , A61K31/704 , A61P31/04 , A61P35/00 , C07H15/244 , C12P19/56 , C12R1/465 , C07H15/00
CPC分类号: C12P19/56 , C07H15/244
摘要: The present invention relates to the compound UCH9 represented by the following formula: ##STR1## which has antibacterial and anti-tumor activity, and pharmaceutically acceptable salts thereof.
摘要翻译: PCT No.PCT / JP94 / 01233 Sec。 371日期1995年04月21日 102(e)1995年4月21日PCT PCT 1994年7月26日PCT公布。 第WO95 / 06054号公报 日期:1995年3月2日本发明涉及由下式表示的化合物UCH9:具有抗菌和抗肿瘤活性的
及其药学上可接受的盐。 -
10.
公开(公告)号:US20130017136A1
公开(公告)日:2013-01-17
申请号:US13636925
申请日:2011-04-05
申请人: Shinya Hirota , Yoshinori Yamashita
发明人: Shinya Hirota , Yoshinori Yamashita
IPC分类号: B01D53/94
CPC分类号: F01N3/208 , B01D53/9409 , B01D53/9495 , B01D2251/2062 , B01D2255/1021 , B01D2255/20738 , B01D2255/50 , B01D2255/911 , F01N11/00 , F01N2560/026 , F01N2560/06 , F01N2570/14 , F01N2570/18 , F01N2610/02 , F01N2900/1402 , F01N2900/1622 , Y02A50/2344 , Y02T10/24 , Y02T10/47
摘要: A NOx selective reduction catalyst for reducing NOx by the ammonia adsorbed is disposed in an engine exhaust gas passage. As states of adsorption of ammonia by the catalyst, there are a first adsorption state of ammonia that occurs when the ammonia is adsorbed during low temperature and a second adsorption state of ammonia that occurs when the ammonia is adsorbed or has already been adsorbed during high temperature. The amount of adsorbed ammonia in the first state is restricted to control concentration of the ammonia that is in the first state and desorbed when the temperature of the catalyst increases so as to be not higher than an allowable concentration, and that in the second state is restricted to control concentration of the ammonia that is in the second state and desorbed when the temperature of the catalyst increases so as to be not higher than an allowable concentration.
摘要翻译: 在发动机废气通道中设置用于通过吸附氨还原NOx的NOx选择还原催化剂。 作为催化剂吸附氨的状态,当氨在低温下被吸附时发生氨的第一吸附状态和当氨吸附或已经在高温下被吸附时发生的氨的第二吸附状态 。 在第一状态下吸附的氨的量被限制为控制处于第一状态并在催化剂的温度升高时脱附的氨的浓度以不高于允许浓度,而在第二状态下的氨的浓度为 限制为控制处于第二状态并在催化剂温度升高时解吸的氨的浓度以不高于允许浓度。
-
-
-
-
-
-
-
-
-